Zhenyu Jia Selected Research

Zhenyu Jia Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 02/2006
15	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 01/2009
3	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 03/2015
3	Breast Neoplasms (Breast Cancer) 07/2017 - 01/2015
2	Ischemia 05/2022 - 01/2019
2	Atrial Fibrillation 04/2022 - 03/2022
2	Disease Progression 11/2021 - 09/2019
2	Malignant Mesothelioma 11/2021 - 10/2017
2	Mesothelioma 11/2021 - 01/2016
2	Inflammation (Inflammations) 01/2018 - 01/2013
2	Carcinogenesis 06/2017 - 01/2014
2	Body Weight (Weight, Body) 03/2014 - 10/2009
2	Pneumonia (Pneumonitis) 03/2014 - 10/2009
1	Thrombosis (Thrombus) 04/2022
1	Ischemic Stroke 03/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Infections 10/2021
1	Stomach Neoplasms (Stomach Cancer) 08/2021
1	Osteoporosis 01/2021
1	Microsatellite Instability 01/2020
1	Necrosis 01/2019
1	Edema (Dropsy) 01/2019
1	Pulmonary Embolism 01/2018
1	Pathologic Processes 01/2018
1	Ankylosing Spondylitis 12/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016
1	Colitis 12/2015

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2008
7	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2013
7	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2015
5	Messenger RNA (mRNA)IBA 01/2018 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2012
2	Competitive Endogenous RNAIBA 12/2021 - 12/2017
2	Biological ProductsIBA 12/2021 - 01/2019
2	MethyltransferasesIBA 01/2020 - 06/2012
2	Phosphotransferases (Kinase)IBA 01/2018 - 10/2017
2	Peptide Initiation Factors (Initiation Factor)IBA 06/2017 - 03/2015
2	AntioxidantsIBA 12/2015 - 05/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2015 - 01/2013
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 04/2015 - 03/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 03/2014 - 10/2009
1	Cytidine Triphosphate (CTP)IBA 05/2022
1	Tirofiban (Aggrastat)FDA Link 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	ElementsIBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2021
1	Heterogeneous-Nuclear Ribonucleoprotein LIBA 12/2021
1	Circular RNAIBA 12/2021
1	ChromatinIBA 11/2021
1	Serpentine Asbestos (Chrysotile)IBA 11/2021
1	CarcinogensIBA 11/2021
1	NucleotidesIBA 10/2021
1	Leucine (L-Leucine)FDA Link 10/2021
1	AlbuminsIBA 08/2021
1	Alkaline PhosphataseIBA 08/2021
1	Smad2 ProteinIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 12/2020
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2019
1	Betulinic AcidIBA 01/2019
1	PlasticsIBA 01/2019
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Estrogen Receptor alphaIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	dCTP pyrophosphataseIBA 10/2018
1	Cyclophilins (Cyclophilin)IBA 01/2018
1	Cyclophilin AIBA 01/2018
1	CytokinesIBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	Sunitinib (Sutent)FDA Link 10/2017
1	Tyrosine Kinase InhibitorsIBA 10/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2017
1	Tyrosine (L-Tyrosine)FDA Link 10/2017
1	AsbestosIBA 10/2017
1	ParaffinIBA 07/2017
1	Formaldehyde (Formol)FDA Link 07/2017
1	Pharmaceutical PreparationsIBA 06/2017
1	mesoglycanIBA 10/2016
1	Gemcitabine FDA Link 10/2016
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2016
1	Cyclin D1IBA 10/2016
1	SurvivinIBA 10/2016
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2016
1	Metformin (Glucophage)FDA LinkGeneric 10/2016
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2016
1	CaspasesIBA 04/2016
1	superoxide dismutase 2IBA 01/2016
1	celastrolIBA 12/2015

Therapy/Procedure

10	Therapeutics 05/2022 - 05/2011
3	Prostatectomy (Retropubic Prostatectomy) 09/2019 - 01/2009
2	Thrombectomy 04/2022 - 03/2022
2	Drug Therapy (Chemotherapy) 01/2022 - 10/2017
1	Adjuvant Chemotherapy 01/2022
1	Stents 01/2022
1	Extracorporeal Shockwave Therapy 01/2021
1	Lasers (Laser) 01/2019